Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

AUPH holding history

Aurinia Pharmaceuticals Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AUPH overviewAll 13F holders of AUPHFull Q2 2026 holdings

Shares (Q2 2026)
1,408,456
Value
$23.9M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AUPH by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,408,456$23.9M<0.1%−164,527−10.5%ReducedHolders
Q1 20261,572,983$23.3M<0.1%+40,710+2.7%AddedHolders
Q4 20251,532,273$24.4M<0.1%+622,351+68.4%AddedHolders
Q3 2025909,922$10.1M<0.1%+568,382+166.4%AddedHolders
Q2 2025341,540$2.89M<0.1%+77,117+29.2%AddedHolders
Q1 2025264,423$2.13M<0.1%+131,090+98.3%AddedHolders
Q4 2024133,333$1.20M<0.1%+39,384+41.9%AddedHolders
Q3 202493,949$688.6K<0.1%+8,055+9.4%AddedHolders
Q2 202485,894$490.5K<0.1%+4,152+5.1%AddedHolders
Q1 202481,742$409.5K<0.1%−10,820−11.7%ReducedHolders
Q4 202392,562$832.1K<0.1%−264,584−74.1%ReducedHolders
Q3 2023357,146$2.78M<0.1%−256,367−41.8%ReducedHolders
Q2 2023613,513$5.94M<0.1%+108,259+21.4%AddedHolders
Q1 2023505,254$5.54M<0.1%+398,970+375.4%AddedHolders
Q4 2022106,284$459.1K<0.1%+6,447+6.5%AddedHolders
Q3 202299,837$751.0K<0.1%−13,723−12.1%ReducedHolders
Q2 2022113,560$1.14M<0.1%+34,647+43.9%AddedHolders
Q1 202278,913$977.0K<0.1%−109,420−58.1%ReducedHolders
Q4 2021188,333$4.31M<0.1%−145,536−43.6%ReducedHolders
Q3 2021333,869$7.39M<0.1%+294,258+742.9%AddedHolders
Q2 202139,611$513.0K<0.1%+27,776+234.7%AddedHolders
Q1 202111,835$154.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.